Spirulina and Hyaluronic Acid

HA: A Megadalton Polysaccharide

Hyaluronic acid (HA, hyaluronan) is a non-sulfated glycosaminoglycan composed of repeating disaccharides of glucuronic acid and N-acetylglucosamine. Synthesized at the plasma membrane by HA synthases (HAS1, HAS2, HAS3) and extruded into the extracellular space, mature HA can reach 6 MDa. Its water-binding capacity (1000× its weight) maintains tissue hydration, joint lubrication, and corneal transparency.

HAS2: The Predominant Isoform

HAS2 produces high-molecular-weight HA, which is anti-inflammatory and CD44-signaling-permissive. HAS3 produces shorter HA (and is upregulated in inflammation). HA fragmentation by hyaluronidases (HYAL1, HYAL2) or ROS generates low-MW HA fragments that are pro-inflammatory through TLR2/TLR4 signaling. Phycocyanin supports HAS2 expression by 20–30% in fibroblasts and reduces ROS-mediated HA depolymerization.

CD44 and HA Receptor Signaling

CD44 is the principal HA receptor, binding HA through its N-terminal link module. CD44-HA interaction supports cell migration, fibroblast activation, and stem cell niches. Pathological CD44 activation drives tumor invasion and fibrosis. Spirulina modulates CD44 in context-dependent fashion — supporting physiological CD44 signaling for tissue repair while suppressing inflammatory CD44 activation.

Skin and Joint Applications

Skin HA content declines ~50% by age 50, contributing to wrinkles, dehydration, and loss of dermal turgor. Spirulina's effects on dermal HAS2 (through reduced UV- and ROS-mediated damage) preserve HA content, with measurable improvements in skin hydration metrics in clinical trials. Synovial HA is similarly preserved in joint health applications.

Hyaluronidase and Aging

HYAL2 cleaves HA at the cell surface; HYAL1 completes degradation in lysosomes. Both are upregulated by inflammation and oxidative stress, accelerating HA loss with age. Phycocyanin's antioxidant and anti-inflammatory effects reduce hyaluronidase expression by 15–25% in aged fibroblasts, preserving HA pool.

Conclusion

Spirulina supports tissue HA content through HAS2 expression upregulation (20–30%), reduced ROS-mediated HA depolymerization, and decreased hyaluronidase expression (15–25%). Clinical correlates include improved skin hydration metrics, preserved joint synovial fluid quality, and corneal hydration. While topical/injectable HA products dominate the market, internal HAS2 support provides a mechanistic basis for spirulina's effects on connective tissue integrity.